Annual Accounts Receivable
N/A
31 December 2023
Summary:
Oncolytics Biotech annual accounts receivable is not available.ONCY Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
N/A
30 September 2024
Summary:
Oncolytics Biotech quarterly accounts receivable is not available.ONCY Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ONCY Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
ONCY Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time |
Oncolytics Biotech Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | $0.00(-100.0%) |
| Mar 2018 | - | $3.79 M(+0.1%) |
| Dec 2017 | $3.79 M(>+9900.0%) | $3.79 M(>+9900.0%) |
| Sept 2017 | - | $26.60 K(-44.4%) |
| June 2017 | - | $47.80 K(+74.5%) |
| Mar 2017 | - | $27.40 K(>+9900.0%) |
| Dec 2016 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2016 | - | $34.20 K(-19.0%) |
| June 2016 | - | $42.20 K(-8.3%) |
| Mar 2016 | - | $46.00 K(-81.2%) |
| Dec 2015 | $245.10 K(+48.4%) | $245.10 K(+520.5%) |
| Sept 2015 | - | $39.50 K(-20.0%) |
| June 2015 | - | $49.40 K(+36.8%) |
| Mar 2015 | - | $36.10 K(-78.1%) |
| Dec 2014 | $165.20 K(+66.2%) | $165.20 K(+117.4%) |
| Sept 2014 | - | $76.00 K(+49.0%) |
| June 2014 | - | $51.00 K(+29.4%) |
| Mar 2014 | - | $39.40 K(-60.4%) |
| Dec 2013 | $99.40 K(+119.9%) | $99.40 K(+189.8%) |
| Sept 2013 | - | $34.30 K(-23.1%) |
| June 2013 | - | $44.60 K(-41.9%) |
| Mar 2013 | - | $76.70 K(+69.7%) |
| Dec 2012 | $45.20 K(-16.8%) | $45.20 K(-50.7%) |
| Sept 2012 | - | $91.60 K(+5.7%) |
| June 2012 | - | $86.70 K(+63.3%) |
| Mar 2012 | - | $53.10 K(-2.2%) |
| Dec 2011 | $54.30 K(-80.9%) | $54.30 K(-27.3%) |
| Sept 2011 | - | $74.70 K(+40.7%) |
| June 2011 | - | $53.10 K(-29.0%) |
| Mar 2011 | - | $74.80 K(-73.7%) |
| Dec 2010 | $284.90 K(+363.3%) | $284.90 K(+856.0%) |
| Sept 2010 | - | $29.80 K(-46.0%) |
| June 2010 | - | $55.20 K(+69.8%) |
| Mar 2010 | - | $32.50 K(-47.2%) |
| Dec 2009 | $61.50 K | $61.50 K(+10.8%) |
| Sept 2009 | - | $55.50 K(-37.1%) |
| June 2009 | - | $88.30 K(+62.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2009 | - | $54.20 K(-22.7%) |
| Dec 2008 | $70.10 K(-12.6%) | $70.10 K(+55.8%) |
| Sept 2008 | - | $45.00 K(-3.0%) |
| June 2008 | - | $46.40 K(-44.0%) |
| Mar 2008 | - | $82.90 K(+3.4%) |
| Dec 2007 | $80.20 K(+11.4%) | $80.20 K(+117.3%) |
| Sept 2007 | - | $36.90 K(-15.9%) |
| June 2007 | - | $43.90 K(-0.5%) |
| Mar 2007 | - | $44.10 K(-38.8%) |
| Dec 2006 | $72.00 K(+76.5%) | $72.00 K(+113.6%) |
| Sept 2006 | - | $33.70 K(-30.5%) |
| June 2006 | - | $48.50 K(-51.7%) |
| Mar 2006 | - | $100.40 K(+146.1%) |
| Dec 2005 | $40.80 K(+2.8%) | $40.80 K(-15.7%) |
| Sept 2005 | - | $48.40 K(-12.6%) |
| June 2005 | - | $55.40 K(+65.4%) |
| Mar 2005 | - | $33.50 K(-15.6%) |
| Dec 2004 | $39.70 K(-19.8%) | $39.70 K(+3.1%) |
| Sept 2004 | - | $38.50 K(-19.3%) |
| June 2004 | - | $47.70 K(+0.4%) |
| Mar 2004 | - | $47.50 K(-4.0%) |
| Dec 2003 | $49.50 K(+60.7%) | $49.50 K(-73.4%) |
| Sept 2003 | - | $186.10 K(+328.8%) |
| June 2003 | - | $43.40 K(+40.0%) |
| Mar 2003 | - | $31.00 K(+0.6%) |
| Dec 2002 | $30.80 K(-48.4%) | $30.80 K(-35.7%) |
| Sept 2002 | - | $47.90 K(+50.6%) |
| June 2002 | - | $31.80 K(-10.2%) |
| Mar 2002 | - | $35.40 K(-40.7%) |
| Dec 2001 | $59.70 K(-35.0%) | $59.70 K(-29.0%) |
| Sept 2001 | - | $84.10 K(+1.3%) |
| June 2001 | - | $83.00 K(+3.1%) |
| Mar 2001 | - | $80.50 K(-12.3%) |
| Dec 2000 | $91.80 K(+575.0%) | $91.80 K(+28.0%) |
| Sept 2000 | - | $71.70 K(-15.7%) |
| June 2000 | - | $85.10 K(+313.1%) |
| Mar 2000 | - | $20.60 K |
| Dec 1999 | $13.60 K | - |
FAQ
- What is the all time high annual accounts receivable for Oncolytics Biotech?
- What is the all time high quarterly accounts receivable for Oncolytics Biotech?
What is the all time high annual accounts receivable for Oncolytics Biotech?
Oncolytics Biotech all-time high annual accounts receivable is $3.79 M
What is the all time high quarterly accounts receivable for Oncolytics Biotech?
Oncolytics Biotech all-time high quarterly accounts receivable is $3.79 M